Star Scientific, Inc.'s primary focus is the research and development of products that deliver less toxins. The Company's overall objective is to reduce the range of serious health hazards associated with the use of smoked tobacco products. Accordingly, its primary corporate mission is to demonstrate the commercial viability of products that deliver less toxins and are potentially less harmful. Star Scientific Inc. has a market cap of $79.1 million; its shares were traded at around $0.77 with and P/S ratio of 175.4. Star Scientific Inc. had an annual average earning growth of 13.5% over the past 5 years.
Insiders' Positions with STSI
- Buy:: CEO, 10% Owner Jonnie Williams bought 50,000 shares of STSI stock on 11/12/2009 at the average price of 0.77, the price of the stock has decreased by 0% since
Insiders' Positions with STSI
- Buy:: President & COO Paul L Perito bought 50,000 shares of STSI stock on 11/12/2009 at the average price of 0.79, the price of the stock has decreased by 2.53% since
- Buy:: General Counsel Robert E Pokusa bought 10,000 shares of STSI stock on 11/12/2009 at the average price of 0.78, the price of the stock has decreased by 1.28% since
Rate This Article: |
![]() |








